EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2008;34:1-8. doi:10.1016/j.ejcts.2008.04.039
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ottavio R. Alfieri
Manuel J. Antunes
Gerard Fournial
Francesco Maisano
Neil Moat
Patrick Nataf
José Luis Pomar
Thomas Walther
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Vahanian, A.
Right arrow Articles by Walther, T.
PubMed
Right arrow Articles by Vahanian, A.
Right arrow Articles by Walther, T.
Related Collections
Right arrow Valve disease


Editorials

Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Alec Vahaniana,*, Ottavio R. Alfierib,**, Nawwar Al-Attara, Manuel J. Antunesc, Jeroen Baxd, Bertrand Cormiere, Alain Cribierf, Peter De Jaegereg, Gerard Fournialh, Arie Pieter Kappeteing, Jan Kovaci, Susanne Ludgatej, Francesco Maisanob, Neil Moatk, Friedrich-Wilhelm Mohrl, Patrick Natafa, Luc Pierardm, José Luis Pomarn, Joachim Schofero, Pilar Tornosp, Murat Tuzcuq, Ben van Houtr, Ludwig K. von Segessers, Thomas Waltherl

a Hôpital Bichat, Paris, France
b Ospedale San Raffaele, Milan, Italy
c University Hospital, Coimbra, Portugal
d Leiden University Medical Center, Leiden, The Netherlands
e Institut Hospitalier Jacques Cartier, Massy, France
f CHU de Rouen, Hôpitaux de Rouen, Hôpital Charles Nicolle, Rouen Cedex, France
g Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
h CHU, Centre Hospitalier de Rangueil, Toulouse, France
i University Hospitals of Leicester, Leicester, UK
j Department of Health, Medicines and Healthcare Products Regulatory Agency, London, UK
k Royal Brompton Hospital, London, UK
l Heart Center Leipzig, University of Leipzig, Leipzig, Germany
m University Hospital Sart Tilman, Liege, Belgium
n Hospital Clinico de Barcelona, University of Barcelona, Barcelona, Spain
o Hamburg University Cardiovascular Center, Hamburg, Germany
p Hospital Universitari Vall d’Hebron, Barcelona, Spain
q Cleveland Clinic, Cleveland, OH, USA
r Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
s CHUV, Lausanne, Switzerland

Received 3 April 2008; received in revised form 3 April 2008; accepted 15 April 2008.

* Corresponding author. Tel.: +33 1 40 25 67 60; fax: +33 1 40 25 67 32. (Email: alec.vahanian{at}bch.aphp.fr; ottavio.alfieri{at}hsr.it).
** Corresponding author. Tel.: +39 02 26437102; fax: +39 02 26 43 7125. (Email: alec.vahanian{at}bch.aphp.fr; ottavio.alfieri{at}hsr.it).

Abstract

Aims: To critically review the available transcatheter aortic valve implantation techniques and their results, as well as propose recommendations for their use and development. Methods and results: A committee of experts including European Association of Cardio-Thoracic Surgery and European Society of Cardiology representatives met to reach a consensus based on the analysis of the available data obtained with transcatheter aortic valve implantation and their own experience. The evidence suggests that this technique is feasible and provides haemodynamic and clinical improvement for up to 2 years in patients with severe symptomatic aortic stenosis at high risk or with contraindications for surgery. Questions remain mainly concerning safety and long-term durability, which have to be assessed. Surgeons and cardiologists working as a team should select candidates, perform the procedure, and assess the results. Today, the use of this technique should be restricted to high-risk patients or those with contraindications for surgery. However, this may be extended to lower risk patients if the initial promise holds to be true after careful evaluation. Conclusion: Transcatheter aortic valve implantation is a promising technique, which may offer an alternative to conventional surgery for high-risk patients with aortic stenosis. Today, careful evaluation is needed to avoid the risk of uncontrolled diffusion.

Key Words: Aortic stenosis • Valve disease • Percutaneous valve interventions




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. P. Dal-Bianco, B. K. Khandheria, F. Mookadam, F. Gentile, and P. P. Sengupta
Management of Asymptomatic Severe Aortic Stenosis
J. Am. Coll. Cardiol., October 14, 2008; 52(16): 1279 - 1292.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.